Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Operating Income of -$108.14 million for fiscal year 2025.
CAPRICOR THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$108.14M | -154.1% |
| 2024 | -$42.56M | -76.8% |
| 2023 | -$24.08M | +18.9% |
| 2022 | -$29.70M | -41.8% |
| 2021 | -$20.94M | -52.9% |
| 2020 | -$13.69M | -77.0% |
| 2019 | -$7.73M | +49.5% |
| 2018 | -$15.33M | -19.2% |
| 2017 | -$12.86M | +24.2% |
| 2016 | -$16.98M | -34.6% |
| 2015 | -$12.61M | -109.6% |
| 2014 | -$6.02M | +12.8% |
| 2013 | -$6.90M | -228.7% |
| 2012 | -$2.10M | +57.1% |
| 2011 | -$4.90M | +22.2% |
| 2010 | -$6.29M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.28M | -102.0% | +5.2% |
| June 30, 2025 | -$27.72M | -139.1% | -11.0% |
| March 31, 2025 | -$24.98M | -143.4% | -92.0% |
| September 30, 2024 | -$13.01M | -89.5% | -12.2% |
| June 30, 2024 | -$11.59M | -49.6% | -12.9% |
| March 31, 2024 | -$10.27M | -25.4% | -49.5% |
| September 30, 2023 | -$6.86M | -6.0% | +11.4% |
| June 30, 2023 | -$7.75M | -5.8% | +5.3% |
- CAPRICOR THERAPEUTICS, INC. showed a decrease of -154.1% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, CAPRICOR THERAPEUTICS, INC.’s operating income has declined by 1618.3% (from -$6.29 million to -$108.14 million).
- The most recent figure is from CAPRICOR THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: